Coated microneedles for transdermal delivery.

By H. Gill, Mark R. Prausnitz. Journal of Controlled Release, 2007

750 citations recorded by the source corpus.

Subfields: Biotechnology, Immunology, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/223ef2f3def47e8eece7d10af52bca6734321c1c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biotechnology

In Immunology

In Pharmaceutical Science

Citations in the corpus

Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety (2010, positive): “Gill and Prausnitz (2007) designed novel MNs with central openings termed ‘pockets’ (Figure 4a), which were dip-coated with model drugs and various surfactants and viscosity enhancers, prepared in aqueous or organic solvents.”
Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin. (2017, methodology): “Microneedles are typically coated either by bringing microneedles to a bath of coating solution or bringing droplets or films of coating solutions to the surface of microneedles (13, 48, 49, 64).”
Microneedles for drug and vaccine delivery (2012, methodology): “Small molecules have been coated, including fluorescein [100], sulforhodamine [101], calcein [46], vitamin B [46], pilocarpine [101], and lidocaine [102].”
Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum (2015, background): “Delivery from coated MN was found to be attractive especially for high molecular weight molecules [146].”
Microneedle technologies for (trans)dermal drug and vaccine delivery. (2012, methodology): “Microneedles have been coated with a broad range of drugs, such as hydrophilic and hydrophobic low-molecular-weight drugs, DNA, RNA, proteins, peptides, inactivated pathogens, and particles [10, 27, 44, 94, 95, 100, 101].”
Transdermal drug delivery (2008, methodology): “We have dip-coated microneedles with a variety of compounds, including small molecules, proteins, DNA and virus particle”
Dissolving microneedles for transdermal drug delivery. (2008, methodology): “Previous approaches have encapsulated drug only within microneedle shafts [8,9,24] or, alternatively, coated drug onto the surface of microneedle shafts [7,10].”
Microneedles: A New Frontier in Nanomedicine Delivery (2016, neutral): “Different strategies can be employed to successfully coat the formulations onto the surface of the MNs (78 – 80).”